Neurological merger

By BC Staff | May 23, 2000 | 7:00 AM GMT

CeNeS (LSE:CEN) will acquire Cambridge Neuroscience (CNSI) for $44 million in stock. The new company will focus on central

Read the full 193 word article

How to gain access

Continue reading with a
two-week free trial.